secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2026-06-04T20:15:59+00:00
Accession:  0001193125-26-257432
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma announces 2026 AGM results; all director nominees elected
------------------------------------------------------------------------

- All 9 director nominees elected with 88.08% quorum; Pablo Legorreta received 458.2M votes for, 29.4M against.
- Say-on-pay (non-binding) approved: 476.0M for, 11.1M against, 0.7M abstain.
- Ratification of Ernst & Young as independent auditor: 506.3M for, 0.8M against, 1.0M abstain.
- UK statutory accounts and reports approved: 487.2M for, 98K against, 0.6M abstain.
- Authorization to allot shares without pre-emption passed: 445.7M for, 42.0M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312526257432/0001193125-26-257432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312526257432/d855771d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-257432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer